Trial Profile
A Phase II Multicenter Study Of Lometrexol Sodium And Folic Acid In Subjects With Previously Treated Stage IIIB or IV Non-Small Cell Lung Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Folic acid (Primary) ; Lometrexol (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Sep 2005 New trial record.